This applies independently of the groups of patients with titin antibodies, including MG patients with thymoma, hyperplastic or involuted thymus, early or late onset of the disease (which may follow different pathogenic mechanisms), or even non-MG patients. Here, TTN is linked to myasthenia gravis.